Odyssey Therapeutics
Data as of .
Company facts
-
Founded
2021
-
Headquarters
United States (Boston, MA)
Latest funding round
- Round
- IPO
- Date
- May 7, 2026
- Amount
- $279M
Drug discovery partners
0 pharma, 1 other. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Evotec CRO
AI-enabled small-molecule discovery collaboration,
Terms not disclosed
Recent news
-
Phase 2a trial design poster at ACG 2026
-
To present the design of a Phase 2a study of OD-001 with vedolizumab at ACG 2026
-
Phase 2a OD-001 results in ulcerative colitis to be presented at UEG Week 2026
-
Evotec AI-enabled small molecule discovery collaboration
-
AI-enabled R&D collaboration with Evotec in autoimmune and inflammatory diseases
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.